Trends in cancer incidence and mortality in Vaud, Switzerland, 1974-1993

Annals of Oncology

Volumn 7, Issue 5, 1996, Pages 497-504

  Levi, F ^a,d   Te, V C ^a   Randimbison, L ^a   La Vecchia, C ^b,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cancer; Epidemiology; Incidence; Mortality; Registry; Time trends

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CHILD; FEMALE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; SWITZERLAND;

EID: 0030016656     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010639     Document Type: Article

References (39)

1. Adami H-O, Sparén P, Bergström R et al. Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst 1989; 81: 1640-7.
2. Doll R. Are we winning the fight against cancer. An epidemiological assessment. Eur J Cancer 1990; 26: 508-9.
3. Levi F, Te VC, Randimbison L, La Vecchia C. Cancer incidence registration and trends in the Canton of Vaud, Switzerland. Eur J Cancer 1991; 27: 207-9.
4. Hill C, Benhamou E, Doyon F. Trends in cancer mortality, France 1950-1985. Br J Cancer 1991; 63: 587-90.
5. Ries LAG, Hankey BF, Miller BA et al. Cancer Statistics Review 1973-1988. National Cancer Institute, Bethesda MD, NIH Publication No. 91-2789, 1991.
6. Adami H-O. What is progress against cancer? Cancer Causes and Control 1993; 4: 483-7.
7. Hoel DG, Davis DL, Miller AB et al. Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst 1992; 84: 313-20.
8. Polednak AP. Trends in cancer incidence in Connecticut, 1935-1991. Cancer 1994; 74: 2863-72.
9. Devesa SS, Blot WJ, Stone Bj et al. Recent trends in the United States. J Natl Cancer Inst 1995; 87: 175-82.
10. McCredie M, Coates MS, Ford JM. The changing incidence of cancer in adults in New South Wales. Int J Cancer 1988; 42: 667-71.
11. Giles G, Farrugia H, Silver B. Cancer registration in Victoria, Australia, 1982-1987. Eur J Cancer 1991; 27: 659-62.
12. Schraub S, Bougeois P, Mercier M. Cancer incidence registration and trends in the Department of Doubs, France. Eur J Cancer 1992; 28: 1759-60.
13. Levi F, Te VC, La Vecchia C. Changes in cancer incidence in the Swiss canton of Vaud, 1978-87. Ann Oncol 1990; 1: 293-7.
14. Levi F, Te VC, Randimbison L et al. Statistics from the registry of the canton of Vaud, Switzerland, 1983-1987. In Parkin DM, Muir CS, Whelan SL et al. (eds): Cancer Incidence in Five Continents, Vol. VI, IARC Scientific Publication No. 120. Lyon: IARC 1992; 762-5.
15. Levi F, Delachaux A, Junod B, Wietlisbach V. Statistics from the registry of the canton of Vaud, Switzerland, 1975-1977. In Waterhouse JAH, Muir CS, Shanmugaratnam K et al. (eds): Cancer Incidence in Five Continents, Vol. IV, IARC Scientific Publication No. 42: Lyon, IARC 1982; 546-9.
16. Levi F, Gutzwiller F, Alaili R et al. Statistics from the registry of the canton of Vaud, Switzerland, 1978-1982. In Muir CS, Waterhouse JAH, Mack T et al. (eds): Cancer Incidence in Five Continents, Vol. V, IARC Scientific Publication No. 88. Lyon: IARC 1987; 634-9.
17. International Classification of Disease for Oncology (ICD-O). Geneva: WHO 1976.
18. Levi F, Randimbison L, Te VC et al. Trends in cancer survival in Vaud, Switzerland. Eur J Cancer 1992; 28: 1490-5.
19. Doll R, Smith PG. Comparison between registries: Age-standardized rates. In Waterhouse JAH, Muir CS, Shanmugaratnam K et al. (eds): Cancer Incidence in Five Continents, Vol. IV, IARC Scient Publ. No. 42. Lyon: IARC 1982; 671-5.
20. Brawer MK, Chetner MP, Beatie J et al. Screening for prostatic carcinoma with prostate-specific antigen. J Urol 1992; 147: 841-5.
21. Jacobsen SJ, Katusic SK, Bergstralh EJ et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 1995; 274: 1445-9.
22. La Vecchia C, Levi F, Lucchini F, Garattini S. Progress of anti-cancer drugs in reducing mortality from selected cancers in Europe: An assessment. Anti-Cancer Drugs 1991; 2: 215-21.
23. Levi F, La Vecchia C, Lucchini F et al. Mortality from Hodgkin's disease and other lymphomas in Europe, 1960-1990. Oncology 1995; 52: 93-6.
24. Levi F, La Vecchia C. Trends in multiple myeloma. Int J Cancer 1990; 46: 755-6.
25. Quinn M, Allen E. Changes of incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ 1995; 311: 391-5.
26. Early Breast Cancer Trialists' Collaborative Group. Systematic treatment of early breast cancer by hormonal cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 1-15, 71-85.
27. Denis LJ. Prostate cancer: A continuum of controversy. Eur J Cancer 1995; 31: 839-40.
28. Catalona W. Management of cancer of the prostate. N Engl J Med 1994; 331: 996-1004.
29. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995; 273: 289-94.
30. White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 1990; 82: 1546-52.
31. Liff JM, Sung JFC, Chow W-H et al. Does increased detection account for the rising incidence of breast cancer? Am J Public Health 1991; 81: 462-5.
32. La Vecchia C, Negri E, Bruzzi P et al. The impact of mammography on breast cancer detection. Ann Oncol 1993; 4: 41-4.
33. La Vecchia C, Levi F, Franceschi S. Screening for cancer, 1995: An update. Ann Oncol 1995; 6: 537-41.
34. Peeters PHM, Verbeek ALM, Straatman H et al. Evaluation of overdiagnosis of breast cancer in screening with mammography. Results of the Nijmegen programme. Int J Epidemiol 1989; 18: 295-9.
35. Boyle P. Epidemiology of breast cancer. Bailliere's Clin Oncol 1988; 2: 1-57.
36. Levi F, Lucchini F, La Vecchia C. Worldwide patterns of cancer mortality, 1985-1989. Eur J Cancer Prev 1994; 3: 109-43.
37. Frey CM, McMillen MM, Cowan CD et al. Representativeness of the Surveillance, Epidemiology and End Results Program data: Recent trends in cancer mortality rates. J Natl Cancer Inst 1992; 84: 872-7.
38. Bonneux L, Barendregt JJ, Looman CWN, van der Maas PJ. Diverging trends in colorectal cancer morbidity and mortality. Earlier diagnosis comes at a price. Eur J Cancer 1995; 31: 1665-71.
39. Adami H-O, Bergstrom R, Sparén P, Baron J. Increasing cancer risk in younger birth cohorts in Sweden. Lancet 1993; 341: 773-7.